C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2

MLA

John Wagstaff, et al. “C1-Inhibitor Substitution Therapy in Septic Shock and in the Vascular Leak Syndrome Induced by High Doses of Interleukin-2.” Intensive Care Medicine, vol. 19, Jan. 1993. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e815bba8dcb5b39207df8b1d6f99ba6c&authtype=sso&custid=ns315887.

APA

John Wagstaff, A. C. Ogilvie, C. E. Hack, B. Eisele, L. G. Thijs, & A. J. M. Eerenberg. (1993). C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Medicine, 19.

Chicago

John Wagstaff, A. C. Ogilvie, C. E. Hack, B. Eisele, L. G. Thijs, and A. J. M. Eerenberg. 1993. “C1-Inhibitor Substitution Therapy in Septic Shock and in the Vascular Leak Syndrome Induced by High Doses of Interleukin-2.” Intensive Care Medicine 19 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e815bba8dcb5b39207df8b1d6f99ba6c&authtype=sso&custid=ns315887.